Warby Parker Inc (WRBY)
16.14
+0.42
(+2.67%)
USD |
NYSE |
May 16, 16:00
16.49
+0.35
(+2.17%)
Pre-Market: 06:35
Warby Parker Revenue (Quarterly): 200.00M for March 31, 2024
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 200.00M |
| December 31, 2023 | 161.86M |
| September 30, 2023 | 169.85M |
| June 30, 2023 | 166.09M |
| March 31, 2023 | 171.97M |
| December 31, 2022 | 146.49M |
| September 30, 2022 | 148.78M |
| June 30, 2022 | 149.62M |
| Date | Value |
|---|---|
| March 31, 2022 | 153.22M |
| December 31, 2021 | 132.89M |
| September 30, 2021 | 137.37M |
| June 30, 2021 | 131.56M |
| March 31, 2021 | 138.97M |
| December 31, 2020 | 112.84M |
| September 30, 2020 | 104.09M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
104.09M
Minimum
Sep 2020
200.00M
Maximum
Mar 2024
148.37M
Average
148.78M
Median
Sep 2022
Revenue (Quarterly) Benchmarks
| AptarGroup Inc | 915.45M |
| Daxor Corp | -- |
| Sanara MedTech Inc | 18.54M |
| Precision Optics Corp Inc | 4.824M |
| Zimmer Biomet Holdings Inc | 1.889B |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | -2.679M |
| Total Expenses (Quarterly) | 205.13M |
| EPS Diluted (Quarterly) | -0.02 |
| Enterprise Value | 1.698B |
| Gross Profit Margin (Quarterly) | 56.73% |
| Profit Margin (Quarterly) | -1.34% |
| Earnings Yield | -2.91% |
| Normalized Earnings Yield | -2.912 |